Genome-Guided Discovery and Biosynthetic Characterization of Burkstatins, Bicyclic Microviridins with Protease Inhibitory Activity

Avatar
Poster
Voice is AI-generated
Connected to paperThis paper is a preprint and has not been certified by peer review

Genome-Guided Discovery and Biosynthetic Characterization of Burkstatins, Bicyclic Microviridins with Protease Inhibitory Activity

Authors

Cheng, Z.; Walker, A.

Abstract

Microviridins are ribosomally synthesized and post-translationally modified peptides characterized by a highly constrained macrocyclic scaffold and potent serine protease inhibitory activity. Unlike canonical tricyclic microviridins, bicyclic microviridins, exemplified by marinostatins, lack the characteristic {omega}-amide linkage. The biosynthetic diversity and biological activities of bicyclic microviridins remain poorly explored. Here, genome mining and phylogenetic analyses revealed diverse lineages of putative bicyclic microviridins, including a conserved family of multicore precursors in Burkholderiaceae. We characterized a representative biosynthetic gene cluster from Paraburkholderia sp. CNPSo 3076 and demonstrated that a single ATP-grasp ligase, BksD, catalyzes the formation of two {omega}-ester macrocycles within each of the two precursor core regions. Heterologous reconstitution and tandem mass spectrometric analyses enabled the production and structural characterization of two bicyclic peptides, designated burkstatin 1 and burkstatin 2. Despite sharing a conserved bicyclic scaffold, the two peptides exhibited distinct serine protease inhibitory profiles. Burkstatin 2 potently inhibited subtilisin and elastase, whereas burkstatin 1 displayed weaker subtilisin inhibition and no detectable elastase inhibition. These findings expand the known biosynthetic and functional diversity of bicyclic microviridins, demonstrate the capacity of a single ATP-grasp ligase to modify multiple core peptides and highlight the influence of core sequence variation on protease inhibitory activity.

Follow Us on

0 comments

Add comment